In the field of geriatric oncology, the CGA can distinguish three broad groups of elderly patients: (1) 'fit' patients, who can be treated with chemotherapy in the same way as younger patients; (2) 'prefrail' patients, for whom chemotherapy should be administered with special schemes, reduced doses and haematological support factors; and (3) 'frail' patients, for whom the best therapeutic option involves supportive care and nonspecific palliative treatment (Balducci, 2007) . However, the authors of the article merely utilised three parameters to decide whether it was possible to administer chemotherapy to the elderly: functional status, as measured by the Lawton -Brody Scale and the Barthel Scale; comorbidity, as measured by the Charlson Index; and the researchers' own subjective opinions. Recently, it has been reported that low scores on the 'Mini Nutritional Assessment' (MNA) questionnaire, which is used to assess nutritional status, and on the 'Mini Mental State Examination' (MMSE), which is used to determine cognitive status, are associated with an increased likelihood of elderly patients being unable to complete chemotherapy. In addition, a low score on the MNA is associated with an increased risk of mortality if chemotherapy is administered to the elderly (Aaldriks et al, 2010) . Such findings indicate that there are sufficient functional status assessment options for elderly patients with cancer.
Based on these data, we strongly advocate that the CGA be used to evaluate elderly patients before the administration of any cancer treatment. Although only a few authors have used specific models of the CGA (Balducci, 2001; Ingram et al, 2002; Repetto et al, 2002; Hurria et al, 2005; Overcash et al, 2006; Molina-Garrido and Guillén-Ponce, 2010) , any of these models could have been applied to this study.
We also believe that the subjective data, though important in subject areas with limited previous research, should be relegated to the background, especially because there is an objective way to evaluate elderly cancer patients: the CGA.
